Physician profile

Jennifer E Keith

Physician Assistant · Bloomington, IN

NPI 1275015901

$7,299.22

in general payments reported to CMS, 2019-2025

44 companies · $1,705 in 2025

The $1,705 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,365.46
Education$456.16
Gift$83.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Biotech, INC. $941.37 2021-2025 Erleada, Akeega, Carvykti
Astellas Pharma US INC $745.99 2021-2025 Xtandi
Accord Healthcare, INC. $619.76 2022-2025
Endo Pharmaceuticals INC. $500.66 2021-2024 Xiaflex, Aveed
Sumitomo Pharma America, INC. $464.28 2023-2025 Gemtesa, Orgovyx
Bayer Healthcare Pharmaceuticals INC. $413.28 2021-2025
Pfizer INC. $389.42 2021-2025
Endo USA, INC. $262.82 2024-2025 Xiaflex, Aveed
Tolmar, INC. $202.50 2023-2025 Jatenzo, Eligard
Antares Pharma, INC. $197.47 2021-2025 Xyosted, Tlando
Abbvie INC. $175.49 2021-2023
Myovant Sciences INC. $175.40 2021-2022
Boston Scientific Corporation $166.50 2021-2023 Rezum Generator
Procept Biorobotics Corporation $159.86 2023-2024 Aquabeam System, Aquabeam Robotic System
Medtronic, INC. $140.29 2021-2025 Interstim, Altaviva
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Genzyme Corporation $131.37 2022-2023
Urovant Sciences INC $127.06 2021-2022
180 Medical, INC. $124.50 2022-2024
Astrazeneca Pharmaceuticals LP $124.48 2021-2025 Lynparza
Sun Pharmaceutical Industries INC. $121.80 2021-2025 Yonsa
Tolmar Pharmaceuticals, INC. $119.69 2021-2022
Progenics Pharmaceuticals, INC. $119.12 2023-2025 Pylarify
Urogen Pharma, INC. $114.37 2023-2025 Jelmyto
Seagen INC. $84.99 2025
Merck Sharp & Dohme LLC $84.09 2024-2025 Keytruda, Lynparza, Welireg
Laborie Medical Technologies Corp. $68.85 2024-2025 Optilume Bph Drug Coated Balloon Catheter
Clarus Therapeutics INC. $67.88 2021
Myriad Genetic Laboratories, INC. $57.42 2021-2025 Prolaris
Verity Pharmaceuticals INC. $56.26 2024 Trelstar
Blue Earth Diagnostics $50.44 2021
Novartis Pharmaceuticals Corporation $48.01 2023-2025
Tempus Ai, INC $43.12 2024
Convatec INC. $31.08 2021
Dentsply Ih INC. $24.27 2022
Ferring Pharmaceuticals INC. $19.50 2024 Adstiladrin
Paratek Pharmaceuticals, INC. $17.23 2023 Nuzyra
Coloplast Corp $16.90 2021
Foundation Medicine, INC. $16.40 2023
Alnylam Pharmaceuticals INC. $16.02 2023 Oxlumo
Halozyme INC $15.03 2023
Acerus Pharmaceuticals Corporation $14.77 2022
Immunitybio, INC. $14.12 2025
Kowa Pharmaceuticals America, INC. $13.16 2023 Seglentis
Travere Therapeutics, INC. $2.20 2023 Thiola

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jennifer E Keith

$7,299.22

in general payments reported 2019-2025

Years
2021-2025
Top company
Janssen Biotech, INC.
Context
The $1,705 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10443104/jennifer-e-keith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.